Skip to main content

HACIA UN TRATAMIENTO FARMACOLOGICO PARA LA DEFICIENCIA EN SYNGAP1. ESTUDIOS PRECLINICOS PARA INVESTIGAR LA EFICACIA DE 4 FARMACOS EN EL RESCATE DE LOS PRINCIPALES FENOTIPOS

RTI2018-097037-B-I00

•
Funding agency name Agencia Estatal de Investigación
Funding agency acronym AEI
Program Programa Estatal de I+D+i Orientado a los Retos de la Sociedad
Call Proyectos I+D+i Retos de Investigación
Call year 2018
State Plan 2017-2020 Plan Estatal de Investigación Científica y Técnica y de Innovación
Beneficiary centre INSTITUT DE RECERCA DE L HOSPITAL DE LA SANTA CREU I SANT PAU

Resultados relacionados

Resultados totales (Incluyendo duplicados): 6
Encontrada(s) 1 página(s)

IRTA Pubpro. Open Digital Archive
Publication Artículo científico (JournalArticle)

Synaptic proteome diversity is shaped by the levels of glutamate receptors and their regulatory proteins

  • Reig-Viader, Rita
  • del Castillo-Berges, Diego
  • Burgas-Pau, Albert
  • Arco-Alonso, Daniel
  • Zerpa-Rios, Oriana
  • Ramos-Vicente, David
  • Picañol, Javier
  • Castellanos, Aida
  • Soto, David
  • Roher, Nerea
  • Sindreu, Carlos
  • Bayés, Àlex
Synapses formed by equivalent pairs of pre- and postsynaptic neurons have similar electrophysiological characteristics, belonging to the same type. However, these are generally confined to microscopic brain regions, precluding their proteomic analysis. This fact has greatly limited our ability to investigate the molecular basis of synaptic physiology. We introduce a procedure to characterise the synaptic proteome of microscopic brain regions and explore the molecular diversity among the synapses forming the trisynaptic circuit in the mouse hippocampus. While we observe a remarkable proteomic diversity among these synapses, we also report that proteins involved in the regulation of the function of glutamate receptors are differentially expressed in all of them. Moreover, neuron-specific gene expression programs would contribute to their regulation. Here, we introduce a combined proteomics and transcriptomics analysis uncovering a previously unrecognized neuron-specific control of synaptic proteome diversity, directed towards the regulation of glutamate receptors and their regulatory proteins., RRV, DdCB, OZR and AB financial support was provided by: PID2024-160538OB-I00, PID2021-124411OB-I00 and RTI2018-097037-B-I00 (MINECO/MCI/AEI/FEDER, EU), Award AC17/00005 by ISCIII through AES2017 and within the NEURON framework, Ramón y Cajal Fellowship (RYC-2011-08391p), IEDI-2017-00822, Universitat Autònoma de Barcelona and AGAUR (2017 SGR 1776 and 2021 SGR 01005). DdCB thanks AGAUR/Generalitat de Catalunya/FEDER, EU for ‘Ajuts per a la contractació de personal investigador novel (FI)’ Ref.2020FI_B00130. All authors thank the CERCA Programme/Generalitat de Catalunya for institutional support. JP, AC and DS were supported by grant from Ministerio de Universidades, Ciencia y Innovación Innovación (PID2020-119932GB-I00, MCIN/ AEI /10.13039/5011000011033) and the María de Maeztu (MDM-2017-0729 to Institut de Neurociencies, Universitat de Barcelona)., info:eu-repo/semantics/publishedVersion
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Genotype-phenotype correlations and putative modifier genes in SYNGAP1 Encephalopathy

  • Aranda, Selena
  • Ribeiro-Constante, Juliana
  • Tristán-Noguero, Alba
  • Moreno-Ruiz, Nerea
  • Arenas, Concepción
  • Martínez Calvo, Fernando Francisco
  • Ibáñez-Micó, Salvador
  • Peña Segura, José Luis
  • Ramos-Fernández, José Miguel
  • Moyano Chicano, María del Carmen
  • Camino León, Rafael
  • Soto-Insuga, Víctor
  • González-Alguacil, Elena
  • Valera Dávila, Carlos
  • Fernández-Jaén, Alberto
  • Plans, Laura
  • Camacho, Ana
  • Visa-Reñé, Nuria
  • Martín-Tamayo Blázquez, María del Pilar
  • Paredes-Carmona, Fernando
  • Marti-Carrera, Itxaso
  • Ginot-Julià, Guillem
  • Hernández-Fabián, Aránzazu
  • Tomàs Daví, Meritxell
  • Casadesús Sànchez, Mercè
  • Cuesta Herraiz, Laura
  • Fuentes Pita, Patricia
  • Bermejo González, Teresa
  • O'Callaghan, Mar
  • Iglesias Santa Polonia, Federico Felipe
  • Cazorla, María Rosario
  • Ferrando Lucas, María Teresa
  • González-Meneses, Antonio
  • Sala-Coromina, Júlia
  • Macaya, Alfons
  • Lasa-Aranzasti, Amaia
  • Cueto-González, Anna Mª
  • Párraga, Francisca Valera
  • Plana, Jaume Campistol
  • Serrano, Mercedes
  • Alonso, Xenia
  • Valenzuela Palafoll, Maria Irene
  • Monteagudo, Eines
  • Alonso-Colmenero, Itziar
  • Sans Capdevila, Oscar
  • Casals, Ferran
  • Cormand, Bru
  • García-Cazorla, Ángeles
  • Bayés, Àlex
  • Mitjans, Marina
Synaptic Ras GTPase-Activating Protein 1 (SynGAP) is a key regulator of synaptic plasticity, neurodevelopment, and neuronal circuit function. It is encoded by the SYNGAP1 gene, in which de novo dominant pathogenic variants are a major cause of SYNGAP1 Encephalopathy, a rare neurodevelopmental disorder characterised by intellectual disability, epilepsy, autistic traits, and other clinical manifestations. While some genetic studies have reported genotype-phenotype correlations in this condition, our understanding of how specific genetic variants contribute to the heterogeneous clinical symptoms remain limited. Here, we analysed a cohort of 44 cases extensively characterised at the phenotypic level to investigate the impact of genetic variants in SYNGAP1 and in potentially modulatory genes on the clinical features of SYNGAP1 Encephalopathy. Our results include the identification of four previously unreported likely pathogenic SYNGAP1 variants associated with the disease. In our cohort, individuals carrying variants within the PH domain of SynGAP exhibit milder phenotypes compared with other patients. Finally, patients harbouring rare or low-frequency variants in SYNGAP1-related genes tend to present with higher global severity. Taken together, these findings suggest that the location of SYNGAP1 variants, together with additional genetic modifiers, may contribute to variability in clinical presentation and disease severity. Further studies in larger cohorts and functional validation are needed to refine genotype-phenotype correlations and to support the development of personalized management strategies., The authors declare that financial support was received for the research, authorship, and/or publication of this article. AG-C is supported by FI21/0073 and FI24/00469 “Instituto de Salud Carlos III (ISCIII)” and “Fondo Europeo de desarrollo regional (FEDER)”. AT-N was supported by a “Margarita Salas” contract from Next-Generation Europe and postdoc mobility grants “EMBO short exchange research” grant and “José Castillejo” grant. AB financial support was provided by: PID2024-160538OB-I00, PID 2021-124411OB-I00 and RTI 2018–097037-B-I00 (MINECO/MCI/AEI/FEDER, EU), Award AC17/00005 by ISCIII through AES2017 and within the NEURON framework, Ramón y Cajal Fellowship (RYC-2011-08391p), IEDI-2017-00822 and AGAUR (2017 SGR 1776 and 2021 SGR 01005). AB and AT-N thank the CERCA Programme/Generalitat de Catalunya for institutional support. NM-R was supported by grant 2021 FI_B_00296 from Agència de Gestió d'Ajuts Universitaris i de Recerca, Generalitat de Catalunya. AC-G is member of the European Reference Network on Rare Congenital Malformations and Rare Intellectual Disability ERN-ITHACA, funded by the European Union, under the grant agreement N°101156387. The study was supported by the generous funding provided by the association of Spanish SYNGAP1-DEE families, SYNGAP1 España. AB and BC wish to thank support from the Spanish Red de Investigación RED2024–154082-T., Funding supporting this study was provided by the Spanish ‘Ministerio de Ciencia, Innovación y Universidades’, funded by MICIU/AEI/10.13039/501100011033/ and FEDER-EU (PID2021-1277760B-I00 and PID2024-158634OB-I00, to BC; PID2022-139740OA-I00 to MMi; PID2021-125106OB-C32 and PID2024-161190OB-C22 to FC), ‘Generalitat de Catalunya/AGAUR’ (2021-SGR-01093, to BC and MMi), ICREA Academia 2021 (to BC), and ‘Fundació La Marató de TV3′ (202218-31, to BC). This article is part of the grant RYC2021-033573-I funded by MCIN/AEI/10.13039/501100011033 and by the European Union “NextGenerationEU/PRTR”. SA is supported by a Juan de la Cierva fellowship from the Spanish Ministry of Science and Innovation (JDC2024-055161-I)., Peer reviewed
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Synaptic proteome diversity is shaped by the levels of glutamate receptors and their regulatory proteins

  • Reig-Viader, Rita
  • del Castillo-Berges, Diego
  • Burgas-Pau, Albert
  • Arco-Alonso, Daniel
  • Zerpa-Rios, Oriana
  • Ramos-Vicente, David
  • Picañol, Javier
  • Castellanos, Aida
  • Soto, David
  • Roher, Nerea
  • Sindreu, Carlos
  • Bayés, Àlex
Synapses formed by equivalent pairs of pre- and postsynaptic neurons have similar electrophysiological characteristics, belonging to the same type. However, these are generally confined to microscopic brain regions, precluding their proteomic analysis. This fact has greatly limited our ability to investigate the molecular basis of synaptic physiology. We introduce a procedure to characterise the synaptic proteome of microscopic brain regions and explore the molecular diversity among the synapses forming the trisynaptic circuit in the mouse hippocampus. While we observe a remarkable proteomic diversity among these synapses, we also report that proteins involved in the regulation of the function of glutamate receptors are differentially expressed in all of them. Moreover, neuron-specific gene expression programs would contribute to their regulation. Here, we introduce a combined proteomics and transcriptomics analysis uncovering a previously unrecognized neuron-specific control of synaptic proteome diversity, directed towards the regulation of glutamate receptors and their regulatory proteins., RRV, DdCB, OZR and AB financial support was provided by: PID2024-160538OB-I00, PID2021-124411OB-I00 and RTI2018-097037-B-I00 (MINECO/MCI/AEI/FEDER, EU), Award AC17/00005 by ISCIII through AES2017 and within the NEURON framework, Ramón y Cajal Fellowship (RYC-2011-08391p), IEDI-2017-00822, Universitat Autònoma de Barcelona and AGAUR (2017 SGR 1776 and 2021 SGR 01005). DdCB thanks AGAUR/Generalitat de Catalunya/FEDER, EU for ‘Ajuts per a la contractació de personal investigador novel (FI)’ Ref.2020FI_B00130. All authors thank the CERCA Programme/Generalitat de Catalunya for institutional support. JP, AC and DS were supported by grant from Ministerio de Universidades, Ciencia y Innovación Innovación (PID2020-119932GB-I00, MCIN/ AEI /10.13039/5011000011033) and the María de Maeztu (MDM-2017-0729 to Institut de Neurociencies, Universitat de Barcelona)., info:eu-repo/semantics/publishedVersion
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Sublayer- and cell-type-specific neurodegenerative transcriptional trajectories in hippocampal sclerosis

  • Cid, Elena|||0000-0003-4852-595X
  • Marquez-Galera, A.|||0000-0001-8400-9640
  • Valero, Manuel|||0000-0001-7860-577X
  • Gal, B.|||0000-0001-5189-1147
  • Medeiros, D.C.|||0000-0003-0243-1309
  • Navarron, C.M.
  • Ballesteros-Esteban, L.
  • Reig-Viader, Rita|||0000-0002-6893-6177
  • Morales, Aixa V.|||0000-0001-6295-5142
  • Fernandez-Lamo, Iván
  • Gomez-Dominguez, D.|||0000-0001-8189-498X
  • Sato, M.
  • Hayashi, Yasunori|||0000-0002-7560-3004
  • Bayés, Àlex|||0000-0002-5265-6306
  • Barco, Ángel
  • Lopez-Atalaya, J.P.
  • Prida, Liset Menéndez de la|||0000-0002-0160-6472
Hippocampal sclerosis, the major neuropathological hallmark of temporal lobe epilepsy, is characterized by different patterns of neuronal loss. The mechanisms of cell-type-specific vulnerability and their progression and histopathological classification remain controversial. Using single-cell electrophysiology in vivo and immediate-early gene expression, we reveal that superficial CA1 pyramidal neurons are overactive in epileptic rodents. Bulk tissue and single-nucleus expression profiling disclose sublayer-specific transcriptomic signatures and robust microglial pro-inflammatory responses. Transcripts regulating neuronal processes such as voltage channels, synaptic signaling, and cell adhesion are deregulated differently by epilepsy across sublayers, whereas neurodegenerative signatures primarily involve superficial cells. Pseudotime analysis of gene expression in single nuclei and in situ validation reveal separated trajectories from health to epilepsy across cell types and identify a subset of superficial cells undergoing a later stage in neurodegeneration. Our findings indicate that sublayer- and cell-type-specific changes associated with selective CA1 neuronal damage contribute to progression of hippocampal sclerosis.
Dipòsit Digital de Documents de la UAB
Publication Artículo de revisión (ReviewArticle)

Endogenous Syngap1 Alpha Splice Forms Promote Cognitive Function and Seizure Protection

  • Kilinc, Murat
  • Arora, Vineet
  • Creson, Thomas K.
  • Rojas, Camilo
  • Le, Aliza A.
  • Lauterborn, Julie
  • Wilkinson, Brent
  • Hartel, Nicolas
  • Graham, Nicholas
  • Reich, Adrian
  • Gou Alsina, Gemma|||0000-0001-7438-2417
  • Araki, Yoichi
  • Bayés, Àlex|||0000-0002-5265-6306
  • Coba, Marcelo P.
  • Lynch, Gary
  • Miller, Courtney A.
  • Rumbaugh, Gumbaugh
Loss-of-function variants in SYNGAP1 cause a developmental encephalopathy defined by cognitive impairment, autistic features, and epilepsy. SYNGAP1 splicing leads to expression of distinct functional protein isoforms. Splicing imparts multiple cellular functions of SynGAP proteins through coding of distinct C-terminal motifs. However, it remains unknown how these different splice sequences function in vivo to regulate neuronal function and behavior. Reduced expression of SynGAP-α1/2 C-terminal splice variants in mice caused severe phenotypes, including reduced survival, impaired learning, and reduced seizure latency. In contrast, upregulation of α1/2 expression improved learning and increased seizure latency. Mice expressing α1-specific mutations, which disrupted SynGAP cellular functions without altering protein expression, promoted seizure, disrupted synapse plasticity, and impaired learning. These findings demonstrate that endogenous SynGAP isoforms with α1/2 spliced sequences promote cognitive function and impart seizure protection. Regulation of SynGAP-α expression or function may be a viable therapeutic strategy to broadly improve cognitive function and mitigate seizure.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Developmental outcome of electroencephalographic findings in SYNGAP1 encephalopathy

  • Ribeiro-Constante, Juliana
  • Tristán Noguero, Alba|||0000-0002-0170-9762
  • Martínez Calvo, Fernando Francisco
  • Ibañez-Mico, Salvador|||0000-0003-4582-6511
  • Peña Segura, José Luis
  • Ramos-Fernández, José Miguel
  • Moyano Chicano, María del Carmen
  • Camino León, Rafael
  • Soto Insuga, Víctor
  • González Alguacil, Elena
  • Valera Dávila, Carlos
  • Fernández-Jaén, Alberto
  • Plans, Laura
  • Camacho, Ana
  • Visa-Reñé, Nuria
  • Martin-Tamayo Blázquez, María del Pilar
  • Paredes-Carmona, Fernando
  • Marti-Carrera, Itxaso
  • Hernández-Fabián, Aránzazu
  • Tomas Davi, Meritxell
  • Casadesús, Mercè
  • Herraiz, Laura Cuesta
  • Pita, Patricia Fuentes
  • Bermejo González, Teresa
  • O'Callaghan, Maria del Mar|||0000-0002-1896-1622
  • Iglesias Santa Polonia, Federico Felipe
  • Cazorla, María Rosario
  • Ferrando Lucas, María Teresa
  • González-Meneses, Antonio
  • Sala-Coromina, Júlia|||0000-0001-5116-6316
  • Macaya Ruiz, Alfons|||0000-0001-7998-4185
  • Lasa-Aranzasti, Amaia|||0000-0002-9136-5106
  • Cueto-González, Anna Mª|||0000-0001-7694-6124
  • Valera Párraga, Francisca
  • Campistol Plana, Jaume
  • Serrano, Mercedes|||0000-0002-2056-2428
  • Alonso, Xenia
  • Castillo Berges, Diego del|||0000-0003-1931-1266
  • Schwartz-Palleja, Marc
  • Illescas, Sofía
  • Ramírez Camacho, Alia
  • Sans Capdevila, Òscar|||0009-0004-9766-8716
  • García-Cazorla, Angels|||0000-0001-9853-688X
  • Bayés, Àlex|||0000-0002-5265-6306
  • Alonso-Colmenero, Itziar
SYNGAP1 haploinsufficiency results in a developmental and epileptic encephalopathy (DEE) causing generalized epilepsies accompanied by a spectrum of neurodevelopmental symptoms. Concerning interictal epileptiform discharges (IEDs) in electroencephalograms (EEG), potential biomarkers have been postulated, including changes in background activity, fixation-off sensitivity (FOS) or eye closure sensitivity (ECS). In this study we clinically evaluate a new cohort of 36 SYNGAP1-DEE individuals. Standardized questionnaires were employed to collect clinical, electroencephalographic and genetic data. We investigated electroencephalographic findings, focusing on the cortical distribution of interictal abnormalities and their changes with age. Among the 36 SYNGAP1-DEE cases 18 presented variants in the SYNGAP1 gene that had never been previously reported. The mean age of diagnosis was 8 years and 8 months, ranging from 2 to 17 years, with 55.9% being male. All subjects had global neurodevelopmental/language delay and behavioral abnormalities; 83.3% had moderate to profound intellectual disability (ID), 91.7% displayed autistic traits, 73% experienced sleep disorders and 86.1% suffered from epileptic seizures, mainly eyelid myoclonia with absences (55.3%). A total of 63 VEEGs were revised, observing a worsening of certain EEG findings with increasing age. A disorganized background was observed in all age ranges, yet this was more common among older cases. The main IEDs were bilateral synchronous and asynchronous posterior discharges, accounting for ≥50% in all age ranges. Generalized alterations with maximum amplitude in the anterior region showed as the second most frequent IED (≥15% in all age ranges) and were also more common with increasing age. Finally, diffuse fast activity was much more prevalent in cases with 6 years or older. To the best of our knowledge, this is the first study to analyze EEG features across different age groups, revealing an increase in interictal abnormalities over infancy and adolescence. Our findings suggest that SYNGAP1 haploinsufficiency has complex effects in human brain development, some of which might unravel at different developmental stages. Furthermore, they highlight the potential of baseline EEG to identify candidate biomarkers and the importance of natural history studies to develop specialized therapies and clinical trials.